Anti-infectives is a general term used to describe any medicine that is capable of inhibiting the spread of an infectious organism or by killing the infectious organism outright.
Highlights
The global Anti-Infective Medications market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Anti-Infective Medications is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Anti-Infective Medications is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Anti-Infective Medications include Abbott, Astellas Pharma, Bayer, Bristol-Myers Squibb, Daiichi Sankyo, GlaxoSmithKline, Merck, Novartis and Pfizer, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Anti-Infective Medications, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-Infective Medications.
The Anti-Infective Medications market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Anti-Infective Medications market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anti-Infective Medications manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Abbott
Astellas Pharma
Bayer
Bristol-Myers Squibb
Daiichi Sankyo
GlaxoSmithKline
Merck
Novartis
Pfizer
Roche
Segment by Type
Antivirals
Antibacterials
Antifungals
Segment by Application
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Anti-Infective Medications manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Anti-Infective Medications in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Anti-Infective Medications 麻豆原创 Overview
1.1 Product Overview and Scope of Anti-Infective Medications
1.2 Anti-Infective Medications Segment by Type
1.2.1 Global Anti-Infective Medications 麻豆原创 Value Comparison by Type (2023-2029)
1.2.2 Antivirals
1.2.3 Antibacterials
1.2.4 Antifungals
1.3 Anti-Infective Medications Segment by Application
1.3.1 Global Anti-Infective Medications 麻豆原创 Value by Application: (2023-2029)
1.3.2 Hospital Pharmacies
1.3.3 Online Pharmacies
1.3.4 Retail Pharmacies
1.4 Global Anti-Infective Medications 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Anti-Infective Medications Revenue 2018-2029
1.4.2 Global Anti-Infective Medications Sales 2018-2029
1.4.3 Global Anti-Infective Medications 麻豆原创 Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Anti-Infective Medications 麻豆原创 Competition by Manufacturers
2.1 Global Anti-Infective Medications Sales 麻豆原创 Share by Manufacturers (2018-2023)
2.2 Global Anti-Infective Medications Revenue 麻豆原创 Share by Manufacturers (2018-2023)
2.3 Global Anti-Infective Medications Average Price by Manufacturers (2018-2023)
2.4 Global Anti-Infective Medications Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Anti-Infective Medications, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Anti-Infective Medications, Product Type & Application
2.7 Anti-Infective Medications 麻豆原创 Competitive Situation and Trends
2.7.1 Anti-Infective Medications 麻豆原创 Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Anti-Infective Medications Players 麻豆原创 Share by Revenue
2.7.3 Global Anti-Infective Medications 麻豆原创 Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Anti-Infective Medications Retrospective 麻豆原创 Scenario by Region
3.1 Global Anti-Infective Medications 麻豆原创 Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Anti-Infective Medications Global Anti-Infective Medications Sales by Region: 2018-2029
3.2.1 Global Anti-Infective Medications Sales by Region: 2018-2023
3.2.2 Global Anti-Infective Medications Sales by Region: 2024-2029
3.3 Global Anti-Infective Medications Global Anti-Infective Medications Revenue by Region: 2018-2029
3.3.1 Global Anti-Infective Medications Revenue by Region: 2018-2023
3.3.2 Global Anti-Infective Medications Revenue by Region: 2024-2029
3.4 North America Anti-Infective Medications 麻豆原创 Facts & Figures by Country
3.4.1 North America Anti-Infective Medications 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Anti-Infective Medications Sales by Country (2018-2029)
3.4.3 North America Anti-Infective Medications Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Anti-Infective Medications 麻豆原创 Facts & Figures by Country
3.5.1 Europe Anti-Infective Medications 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Anti-Infective Medications Sales by Country (2018-2029)
3.5.3 Europe Anti-Infective Medications Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Anti-Infective Medications 麻豆原创 Facts & Figures by Country
3.6.1 Asia Pacific Anti-Infective Medications 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Anti-Infective Medications Sales by Country (2018-2029)
3.6.3 Asia Pacific Anti-Infective Medications Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Anti-Infective Medications 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Anti-Infective Medications 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Anti-Infective Medications Sales by Country (2018-2029)
3.7.3 Latin America Anti-Infective Medications Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Anti-Infective Medications 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Anti-Infective Medications 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Anti-Infective Medications Sales by Country (2018-2029)
3.8.3 Middle East and Africa Anti-Infective Medications Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Anti-Infective Medications Sales by Type (2018-2029)
4.1.1 Global Anti-Infective Medications Sales by Type (2018-2023)
4.1.2 Global Anti-Infective Medications Sales by Type (2024-2029)
4.1.3 Global Anti-Infective Medications Sales 麻豆原创 Share by Type (2018-2029)
4.2 Global Anti-Infective Medications Revenue by Type (2018-2029)
4.2.1 Global Anti-Infective Medications Revenue by Type (2018-2023)
4.2.2 Global Anti-Infective Medications Revenue by Type (2024-2029)
4.2.3 Global Anti-Infective Medications Revenue 麻豆原创 Share by Type (2018-2029)
4.3 Global Anti-Infective Medications Price by Type (2018-2029)
5 Segment by Application
5.1 Global Anti-Infective Medications Sales by Application (2018-2029)
5.1.1 Global Anti-Infective Medications Sales by Application (2018-2023)
5.1.2 Global Anti-Infective Medications Sales by Application (2024-2029)
5.1.3 Global Anti-Infective Medications Sales 麻豆原创 Share by Application (2018-2029)
5.2 Global Anti-Infective Medications Revenue by Application (2018-2029)
5.2.1 Global Anti-Infective Medications Revenue by Application (2018-2023)
5.2.2 Global Anti-Infective Medications Revenue by Application (2024-2029)
5.2.3 Global Anti-Infective Medications Revenue 麻豆原创 Share by Application (2018-2029)
5.3 Global Anti-Infective Medications Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Abbott
6.1.1 Abbott Corporation Information
6.1.2 Abbott Description and Business Overview
6.1.3 Abbott Anti-Infective Medications Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Abbott Anti-Infective Medications Product Portfolio
6.1.5 Abbott Recent Developments/Updates
6.2 Astellas Pharma
6.2.1 Astellas Pharma Corporation Information
6.2.2 Astellas Pharma Description and Business Overview
6.2.3 Astellas Pharma Anti-Infective Medications Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Astellas Pharma Anti-Infective Medications Product Portfolio
6.2.5 Astellas Pharma Recent Developments/Updates
6.3 Bayer
6.3.1 Bayer Corporation Information
6.3.2 Bayer Description and Business Overview
6.3.3 Bayer Anti-Infective Medications Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Bayer Anti-Infective Medications Product Portfolio
6.3.5 Bayer Recent Developments/Updates
6.4 Bristol-Myers Squibb
6.4.1 Bristol-Myers Squibb Corporation Information
6.4.2 Bristol-Myers Squibb Description and Business Overview
6.4.3 Bristol-Myers Squibb Anti-Infective Medications Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Bristol-Myers Squibb Anti-Infective Medications Product Portfolio
6.4.5 Bristol-Myers Squibb Recent Developments/Updates
6.5 Daiichi Sankyo
6.5.1 Daiichi Sankyo Corporation Information
6.5.2 Daiichi Sankyo Description and Business Overview
6.5.3 Daiichi Sankyo Anti-Infective Medications Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Daiichi Sankyo Anti-Infective Medications Product Portfolio
6.5.5 Daiichi Sankyo Recent Developments/Updates
6.6 GlaxoSmithKline
6.6.1 GlaxoSmithKline Corporation Information
6.6.2 GlaxoSmithKline Description and Business Overview
6.6.3 GlaxoSmithKline Anti-Infective Medications Sales, Revenue and Gross Margin (2018-2023)
6.6.4 GlaxoSmithKline Anti-Infective Medications Product Portfolio
6.6.5 GlaxoSmithKline Recent Developments/Updates
6.7 Merck
6.6.1 Merck Corporation Information
6.6.2 Merck Description and Business Overview
6.6.3 Merck Anti-Infective Medications Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Merck Anti-Infective Medications Product Portfolio
6.7.5 Merck Recent Developments/Updates
6.8 Novartis
6.8.1 Novartis Corporation Information
6.8.2 Novartis Description and Business Overview
6.8.3 Novartis Anti-Infective Medications Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Novartis Anti-Infective Medications Product Portfolio
6.8.5 Novartis Recent Developments/Updates
6.9 Pfizer
6.9.1 Pfizer Corporation Information
6.9.2 Pfizer Description and Business Overview
6.9.3 Pfizer Anti-Infective Medications Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Pfizer Anti-Infective Medications Product Portfolio
6.9.5 Pfizer Recent Developments/Updates
6.10 Roche
6.10.1 Roche Corporation Information
6.10.2 Roche Description and Business Overview
6.10.3 Roche Anti-Infective Medications Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Roche Anti-Infective Medications Product Portfolio
6.10.5 Roche Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Anti-Infective Medications Industry Chain Analysis
7.2 Anti-Infective Medications Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Anti-Infective Medications Production Mode & Process
7.4 Anti-Infective Medications Sales and 麻豆原创ing
7.4.1 Anti-Infective Medications Sales Channels
7.4.2 Anti-Infective Medications Distributors
7.5 Anti-Infective Medications Customers
8 Anti-Infective Medications 麻豆原创 Dynamics
8.1 Anti-Infective Medications Industry Trends
8.2 Anti-Infective Medications 麻豆原创 Drivers
8.3 Anti-Infective Medications 麻豆原创 Challenges
8.4 Anti-Infective Medications 麻豆原创 Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Abbott
Astellas Pharma
Bayer
Bristol-Myers Squibb
Daiichi Sankyo
GlaxoSmithKline
Merck
Novartis
Pfizer
Roche
听
听
*If Applicable.